These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 425634)

  • 21. [Combined treatment with ipratropin and fenoterol in chronic obstructive lung disease].
    Langaker O
    Tidsskr Nor Laegeforen; 1982 Mar; 102(9-10):558-9. PubMed ID: 6218649
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence on the depth of inhalation on the effect of the beta 2-receptor-stimulating drug fenoterol hydrobromide (berotec).
    Vanderschueren RG; Laros CD; Swierenga J
    Respiration; 1979; 37(6):318-27. PubMed ID: 451364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal inhalation procedure for the fenoterol powder inhaler.
    Groth S; Dirksen H
    Eur J Respir Dis Suppl; 1983; 130():17-24. PubMed ID: 6581057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of bronchodilator and extrabronchial action of salbutamol Polfa-aerosol in comparison with Ventolin Pliva, Berotec Boehringer Ingelheim and Astmopent Polfa in patients with chronic obstructive bronchitis.
    Roźniecki J; Gondorowicz K; Szmidt M; Grabski W
    Mater Med Pol; 1978; 10(2):139-45. PubMed ID: 703389
    [No Abstract]   [Full Text] [Related]  

  • 25. Fenoterol plus ipratropium ('Duovent') aerosol therapy delivered by a tube spacer.
    Woodcock A; Humberstone A; Sutton B; Law A; Lytton S; Newey M; Pike S
    Pharmatherapeutica; 1984; 4(1):32-5. PubMed ID: 6239292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Open assessment of fenoterol (Berotec).
    Deloughery M; Gilmore D
    Med J Aust; 1979 Apr; 1(8):341. PubMed ID: 449817
    [No Abstract]   [Full Text] [Related]  

  • 27. [Relation between indicators of respiratory tract patency and intrapulmonary distribution of ventilation in patients with chronic obstructive bronchopulmonary disease after combined administration of aminophylline and fenoterol].
    Mayer M; Dúbrava I; Strmen J; Dúbravová H
    Bratisl Lek Listy; 1987 May; 87(5):606-15. PubMed ID: 3651856
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative evaluation of the bronchospasmolytic action of fenoterol and iprafen].
    De Maria C; Casazza G
    Arch Monaldi; 1984; 39(3):223-5. PubMed ID: 6242134
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison between aerosol and inhaled powder administration of fenoterol in adult asthmatics.
    Harris R; Rothwell RP
    N Z Med J; 1981 Dec; 94(697):421-2. PubMed ID: 7038565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of the simultaneous aerosol administration of fenoterol and 2(alpha-thenoylthio)propionylglycine].
    Ardizzi A; Della Toffola A; Galietti F; Giorgis GE; Miravalle C; Oliaro A; Scappaticci E
    Minerva Med; 1986 Oct; 77(39):1823-6. PubMed ID: 3534632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the bronchodilating action and of the tolerance of fenoterol and isoproterenol aerosols.
    Sasaki T; Sasaki H; Sugiyama M; Nakamura M; Takishima T
    Rev Inst Hyg Mines (Hasselt); 1979; 34(3):124-33. PubMed ID: 552657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Basic medication of chronic obstructive lung disease with berodual].
    Melent'eva EM
    Klin Med (Mosk); 1999; 77(7):47-8. PubMed ID: 10483166
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fenoterol in the treatment of bronchial obstruction in chronic asthmatiform bronchitis].
    Montanari S; Pasqua F; Gramiccioni E
    Clin Ter; 1982 Jul; 102(2):131-8. PubMed ID: 6216039
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of berotec and atropine on the ventilatory function and blood gases in patients with chronic bronchitis].
    Kurgan J
    Pol Tyg Lek; 1983 Jan; 38(5):149-51. PubMed ID: 6408625
    [No Abstract]   [Full Text] [Related]  

  • 35. [Multicenter clinical study on the delayed use of ipratropium-fenoterol in broncho-obstructive pathology].
    Babich S; Bariffi F; Bisetti A; Carnimeo N; Cavalli A; Corda M; De Michele G; Girbino G; Mancini PA; Melica A
    Arch Monaldi; 1983; 38(5-6):305-16. PubMed ID: 6238585
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of aerosols in obstructive respiratory tract diseases. Clinical-pharmacological studies using fenoterol, salbutamol, ipratropium bromide and terbutaline].
    Kaik G
    Schweiz Med Wochenschr; 1977 Dec; 107(52):1948-57. PubMed ID: 145654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a fenoterol/ipratropium combination with salbutamol from metered dose inhalers in subjects with chronic partially reversible airways obstruction.
    Crane J; Gamble S; Purdie G
    N Z Med J; 1987 Jun; 100(826):385-7. PubMed ID: 2967448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of the bronchodilating effect of SCH 1000, berotec and of the association of the two drugs in patients with spastic bronchitis (author's transl)].
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1974; 65(5):534-9. PubMed ID: 4282820
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect duration and treatment effectiveness of salmeterol, fenoterol and salbutamol in severe forms of respiratory tract obstruction].
    Vollmer M; Schmidt EW; Ulmer WT
    Pneumologie; 1995 Oct; 49(10):528-34. PubMed ID: 8584522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tocolytic treatment with Berotec aerosol].
    Kovács L; Herczeg J
    Orv Hetil; 1978 Feb; 119(9):537-8. PubMed ID: 634613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.